Filing Details

Accession Number:
0001104659-21-141628
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-19 08:13:32
Reporting Period:
2021-11-17
Accepted Time:
2021-11-19 08:13:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750149 Inhibikase Therapeutics Inc. IKT Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827621 H. Milton Werner 3350 Riverwood Parkway Se, Suite 1900
Atlanta GA 30339
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-17 17,569 $1.98 23,589 No 4 P Indirect Domestic Partner
Common Stock Acquisiton 2021-11-17 1,100 $1.97 23,589 No 4 P Indirect Domestic Partner
Common Stock Acquisiton 2021-11-17 3,186 $1.96 23,589 No 4 P Indirect Domestic Partner
Common Stock Acquisiton 2021-11-17 1,334 $1.94 23,589 No 4 P Indirect Domestic Partner
Common Stock Acquisiton 2021-11-17 400 $1.93 23,589 No 4 P Indirect Domestic Partner
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Domestic Partner
No 4 P Indirect Domestic Partner
No 4 P Indirect Domestic Partner
No 4 P Indirect Domestic Partner
No 4 P Indirect Domestic Partner
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,293,580 Direct
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.